Drugs / RO5508887
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01664143 | Jul → Sep 2012 | — | Hoffmann-La Roche | Completed | No outcome recorded |
| Phase 1 | NCT01592331 | May → Oct 2012 | — | Hoffmann-La Roche | Completed | No outcome recorded |
| Phase 1 | NCT01461967 | Sep → Dec 2011 | — | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO5508887 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01664143 ↗ |
| Route | Oral | “Following Oral Administration” NCT01461967 ↗ |